QualityStocksNewsBreaks Archives - Page 852 of 1481

TuesdayJan 12, 2021 9:52 am

QualityStocksNewsBreaks – Loop Insights Inc. (TSXV: MTRX) (OTCQB: RACMF) Enters LOI with Leading European Digital Wallet and Mobile Marketing Company

Loop Insights (TSXV: MTRX) (OTCQB: RACMF), a provider of contactless solutions and artificial intelligence (“AI”) to drive real-time insights, enhanced customer engagement and automated venue tracing to the brick-and-mortar space, today announced its entry into a letter of intent (“LOI”) to acquire Passcreator, a leading European digital wallet and mobile marketing company with Tier-1 clients such as Mercedes-Benz and BMW. According to the update, the acquisition is expected to be completed by late January or early February 2021, subject to customary due diligence and Exchange approvals. “In our December 29th review, I stated that Loop was very confident that significant…

TuesdayJan 12, 2021 9:31 am

QualityStocksNewsBreaks – Cybin Inc. (NEO: CYBN) Announces API Synthesis of Multiple Tryptamine Derivatives

Cybin (NEO: CYBN), a life sciences company focused on psychedelic pharmaceutical therapies, is pleased to announce that Adelia Therapeutics Inc., a wholly-controlled subsidiary of Cybin, has achieved the earn-out milestones for the period commencing Nov. 15, 2020, as contemplated by the terms of a contribution agreement (the “ transaction agreement”) dated Dec. 4, 2020. According to the update, the agreement is among Cybin, Cybin Corp., Cybin US Holdings Inc. (“ Acquiror ”), a wholly-controlled subsidiary of Cybin, and all of the previous shareholders of Adelia (the “ Adelia Shareholders ”). Per the terms of the agreement, an aggregate of 51,163.1…

TuesdayJan 12, 2021 9:10 am

QualityStocksNewsBreaks – Friendable Inc. (FDBL) Announces Record Number of Artist Sign-Ups, Plans to Scale on ‘All Fronts’ in New Year

Friendable (OTC: FDBL) wrapped up the year 2020 with more than 700 new artists joining its exclusive Fan Pass platform since its July launch. The mobile technology and marketing company, which is focused on connecting and engaging users through proprietary mobile and desktop applications, reported that more artists are signing up every day for Fan Pass. FDBL noted that the growth is coming primarily from up-and-coming artists and middle-tier performers as well as those seeking to release previous performances, or gigs, with live-streaming or virtual events. The platform also offers artists the opportunity to sell merchandise and schedule and manage…

MondayJan 11, 2021 1:43 pm

QualityStocksNewsBreaks – Knightscope Inc. Expresses Gratitude to Investors

Knightscope, a developer of advanced physical security technologies utilizing fully autonomous security robots (“ASRs”), has announced that that it has over 18,000 investors! In the update, the company expressed its gratitude to its investors for their unwavering support through both the good and tough times on the rollercoaster of a ride that is a startup. Knightscope is excited for 2021 as it continues to grow the company and wishes everyone a safe and rewarding year. To view the full update, visit https://ibn.fm/YGIw8 About Knightscope Knightscope is an advanced security technology company based in Silicon Valley that builds fully autonomous security…

MondayJan 11, 2021 1:23 pm

QualityStocksNewsBreaks – Processa Pharmaceuticals Inc. (NASDAQ: PCSA) to Present at H.C. Wainwright BIOCONNECT 2021

Processa Pharmaceuticals (NASDAQ: PCSA), a clinical-stage biopharmaceutical company developing products to improve the survival and/or quality of life for patients who have unmet medical needs, today announced that management will present at the H.C. Wainwright BIOCONNECT 2021 Virtual Conference. According to the update, the presentation is now available for on-demand listening by visiting https://ibn.fm/OVOdD. In addition, the press release can also be viewed on the company’s website. To view the full press release, visit https://ibn.fm/EBAN7 About Processa Pharmaceuticals Inc. The mission of Processa is to develop products with existing clinical evidence of efficacy for patients with unmet or underserved medical…

MondayJan 11, 2021 12:57 pm

QualityStocksNewsBreaks – Wrap Technologies Inc. (NASDAQ: WRAP) Announces Strategic Appointments of Chiefs Kathleen O’Toole and Sylvia Moir

Wrap Technologies (NASDAQ: WRAP), an innovator of modern policing solutions, today announced the appointment of Kathleen O’Toole, retired commissioner of Boston and Seattle Police Departments, and Sylvia Moir, retired chief of Tempe Police Department, to join the company’s public safety technology development and agency relations efforts. “As WRAP continues to drive innovations in public safety, we are proud to welcome two highly accomplished leaders,” said Tom Smith, president and interim CEO at WRAP. “Ret. Chief O’Toole and Ret. Chief Moir each hold decades of career experience in law enforcement as well as historic positions as inaugural female chiefs of their…

MondayJan 11, 2021 12:30 pm

QualityStocksNewsBreaks – Foresight Autonomous Holdings Ltd. (NASDAQ: FRSX) (TASE: FRSX) to Present at CES 2021 Virtual Conference

Foresight Autonomous Holdings (NASDAQ: FRSX) (TASE: FRSX), an innovator in automotive vision systems, today announced that it will exhibit virtually at the CES 2021 all digital event, Jan. 12-14, 2021. According to the update, the company will present the latest developments to its proprietary automatic calibration software solution, designed to ensure that stereo cameras remain calibrated regardless of their configuration or position, to create accurate and continuous depth perception. In addition, Foresight will discuss how its unique solution enables separation of stereo cameras in order to allow flexible placement of cameras on the vehicle, increase the baseline between the cameras,…

MondayJan 11, 2021 12:10 pm

QualityStocksNewsBreaks – 180 Life Sciences Corp. (NASDAQ: ATNF) to Present at the Biotech Showcase(TM) Digital 2021 Conference

180 Life Sciences (NASDAQ: ATNF), a clinical-stage biotechnology company with its lead indication in Phase 2b/3, focused on the development of novel drugs that fulfill unmet needs in inflammatory diseases, fibrosis and pain, today announced that it will present at the Biotech Showcase(TM) Digital 2021 Conference. According to the update, the conference is taking place online between January 11-15 and will feature prerecorded sessions of company presentations. Dr. James Woody, Chief Executive Officer, will provide an overview of 180 Life Sciences and the company’s progress in key programs. In addition, 180 Life Sciences will host one-on-one meetings with investors and…

MondayJan 11, 2021 11:47 am

QualityStocksNewsBreaks – Champignon Brands Inc. (CSE: SHRM) (OTCQB: SHRMF) (FWB: 496) Announces New CFO, General Counsel

Champignon Brands (CSE: SHRM) (OTCQB: SHRMF) (FWB: 496) chairman and CEO Roger McIntyre today announced the company's appointment of Stephen R. Brooks as its new chief financial officer and Peter Rizakos as the firm's new general counsel. According to the update, these appointments complete the company's new top management team put into place by Dr. McIntyre and the Champignon Board of Directors. "These new management additions ready us for the future where the Company's clinical products and services will help meet the enormous public need that is creating significant public demand for improved, ketamine-based treatments that are capable of rapid response…

MondayJan 11, 2021 11:19 am

QualityStocksNewsBreaks – Cybin Inc. (NEO: CYBN) Announces Strategic Partnership with Kernel

Cybin (NEO: CYBN), a life sciences company focused on psychedelic pharmaceutical therapies, is excited to announce that it has entered into an agreement with neurotech pioneer HI, LLC dba Kernel (“Kernel”) to leverage its innovative technology, Kernel Flow (“Flow”), for its upcoming sponsored clinical work. “Access to Kernel’s innovative Flow technology adds another exciting dimension to the investigative work that Cybin is doing to develop breakthrough treatments for mental health disorders such as depression and addiction. Currently, clinical investigators rely on limited subjective information from patients. The ability to collect quantitative data from our sponsored drug development programs is potentially…

Site Search

Company Search

Category: QualityStocksNewsBreaks